INCYTE CORP (INCY)
About INCYTE CORP
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $5.1B
- Net income
- $1.3B
- Total assets
- $7.0B
- Market cap
- $23.5B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $23.5B
- Shares outstanding
- 207.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 3, 1993
Incyte Corp (INCY) Stock Price
- Profitable — net income of $1.3B in FY2025.
- Trading 13% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review INCYTE CORP.
Write a review
News about INCYTE CORP
News & sentiment via Polygon.io
Incyte Corp: frequently asked questions
Is Incyte Corp an American company?
Yes — Incyte Corp is an American company. Incyte Corp is incorporated in Delaware, United States and headquartered in Wilmington, Delaware. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Incyte Corp incorporated?
Incyte Corp is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns Incyte Corp?
Incyte Corp reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Incyte Corp traded on a US stock exchange?
Yes — Incyte Corp trades under the ticker INCY on the NASDAQ.
Where is Incyte Corp headquartered?
Incyte Corp is headquartered in Wilmington, Delaware, United States.
Is Incyte Corp publicly traded?
Yes — Incyte Corp is a publicly traded company. Its stock trades under the ticker symbol INCY on the NASDAQ.
What does Incyte Corp do?
Incyte Corp is an American Pharmaceuticals company in the Health & Beauty sector.
When was Incyte Corp founded?
Incyte Corp was founded in 2001.
